Pharma IQ Members

Articles

89 results
of 9
September 13, 2017 by Andrew Love
risk thumb
Andrew Love assesses how to avoid the supply risk when working with CMOs on serialization. In this article, he reveals another six learnings covering everything from project design to catering for ongoing change.
Tags:
July 27, 2017 by Andrew Love
Andrew Love
This is the second article in a series looking at how to avoid the supply risk when working with CMOs on serialization. In this article Andrew Love discusses another six learnings covering everything from resource-planning to clarifying your RACI.
Tags:
July 14, 2017 by Chanice Henry
Chan
The FDA has published draft guidance proposing a 12 month grace period on the enforcement of November’s DSCSA requirements. Even still the industry should continue serialization projects to secure supply chains ahead of 2017's deadline.
Tags: pharma | serialisation | serialization | pharmaceutical | medicines | supply | supply chain | logistics | drug | drugs | pharma firm | big pharma | supply chain security
June 29, 2017 by Andrew Love
Andrew Love
The complex, evolving, immature and increasingly resource-constrained area of serialization means that the risk of significant supply interruptions is high. Expert Andrew Love presents six of his key learnings in this area.
Tags:
December 21, 2016 by Pharma Logistics IQ News
Cold Chain IQ News
The world of Pharma Logistics didn't take its foot off the gas as the year drew to a close. The fourh quarter of 2016 saw prospects grow stronger for the launch of a debut composite refridgerated trailer in North America, new guidelines from the EMA and an investigation into a suspected pharma supply chain breach.
Tags:
November 24, 2016 by Andrew Love
Andrew Love
In the previous article we looked at the development of standard solutions, the need for appropriate levels of resourcing, provision of the right leadership and the need to stay abreast of the continually evolving legislation. In this, the final article in this series, we look at the remaining three learning points – the involvement of local Read more
Tags:
November 3, 2016 by Matthew Paisley
Serialization, serialisation, directive, data, data structure, label, code, master data, CMO, aggregation, pharma, pharmaceutical
As the pharmaceutical industry prepares itself for serialization, many questions arise in regards to best practices that will ensure product traceability throughout the supply chain and compliance on an international scale
Tags:
October 27, 2016 by Andrew Love
Andrew Love
In my last article I talked about selecting global solutions, the risk of an overstretched supply chain, the need to fully understand your supply chain and undertaking a thorough impact assessment across the organisation. In this next article, covering tips 7, 8, 9, and 10, I talk about our next four learning points.
Tags:
October 14, 2016 by Dr. Roland Klüber
roland
The dialogue surrounding supply chain visibility in the pharma arena is surging. However, some companies are known to have previously postponed their visibility projects for other priorities. As a result, few are known to be reaping the full benefits from mastering supply chain visibility.
Tags:
October 5, 2016 by Pharma Logistics IQ
News, pharma, supply chain, pharmaceutical, pharmaceuticals, medicines, supply, MHRA, Cold Chain Technologies, American airlines, Electronic Vaccine Intelligence Network, Massachusetts Institute of TechnologiesPakistan’s Expanded Program on Immunization
Following the quarter which saw the launch of the first solid phase change of material (PCM) Pharma Logistics IQ brings you the highlights of pharma supply chain news in the third quarter of 2016.
Tags:
89 results
of 9